Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Benedictuson Dec 01, 2023 11:22pm
248 Views
Post# 35764800

RE:RE:RE:RE:Various thoughts

RE:RE:RE:RE:Various thoughts
Oilminerdeluxe wrote: Those j/v's take time to get done. Hopefully, something will happen to break the shackles. Not so sure what will happen if they need to raise again in a few months at these prices. Who will participate if not much has happened by then. 

Agreed. Dr Lbiati was hired in early June and in the same NR, the CoB stated: "Based on this latest interim clinical data, the Company is commencing to actively explore international partnering, licensing and distribution opportunities for our cancer targeting PDC, Ruvidar™."
So, theoretically they are 5 months into this process. With the cash runway probably ending somewhere in the March/April area, that is another 4 - 5 months for ongoing discussions/negotiations to take place but the question remains: does a potential partner want the BTD validation first? 
<< Previous
Bullboard Posts
Next >>